Frontiers in Immunology | Vaccines and Molecular Therapeutics

Brief Research Report

Published on 20 Jan 2025

Lymphoma patients treated with anti-CD20 and chemotherapy display disconnected T and B cell responses to COVID-19 vaccine

in Vaccines and Molecular Therapeutics

Sylvain Lamure
Houria Hendel Chavez
Marie-Ghislaine de Goër de Herve
Luc-Matthieu Fornecker
Bernard Drenou
Caroline Jacquet
Fatiha Merabet
Milena Kohn
Florence Quélin
Angela Jackson

Frontiers in Immunology

doi 10.3389/fimmu.2024.1524813

110 views

Original Research

Published on 20 Jan 2025

Brucella suis ΔmapB outer membrane vesicles as an acellular vaccine against systemic and mucosal B. suis infection

in Vaccines and Molecular Therapeutics

Florencia Muñoz González
Magali G. Bialer
Maria L. Cerruti
Silvia M. Estein
Lila Y. Ramis
Pablo C. Baldi
Ángeles Zorreguieta
Mariana C. Ferrero

Frontiers in Immunology

doi 10.3389/fimmu.2024.1501791

Original Research

Published on 20 Jan 2025

Serological cross-reactivity between Crimean-Congo haemorrhagic fever virus and Nairobi sheep disease virus glycoprotein C

in Vaccines and Molecular Therapeutics

Emmanuel A. Maze
George Booth
Georgina Limon
Sandra Belij-Rammerstorfer
Simona R. Tchakarova
Tsviatko Alexandrov
Clare Browning
Ginette Wilsden
Anna B. Ludi
Bryan Charleston

Frontiers in Immunology

doi 10.3389/fimmu.2024.1423474

225 views

Original Research

Published on 17 Jan 2025

Aspartate aminotransferase to platelet ratio correlates with poor prognosis and metabolic alterations in Dabie bandavirus infection

in Vaccines and Molecular Therapeutics

Chunxia Guo
Ruixue Li
Xia Wang
Xiulan Peng

Frontiers in Immunology

doi 10.3389/fimmu.2024.1471511

140 views

Editorial

Published on 16 Jan 2025

Editorial: Immune studies of SARS-CoV2 and vaccines using preclinical modeling

in Vaccines and Molecular Therapeutics

Cordelia Dunai
Smita S. Iyer
William J. Murphy

Frontiers in Immunology

doi 10.3389/fimmu.2024.1548624

348 views

Original Research

Accepted on 15 Jan 2025

Adjuvant-free, self-assembling ferritin nanoparticle vaccine coupled with influenza virus hemagglutinin protein carrying M1 and PADRE epitopes elicits cross-protective immune responses

in Vaccines and Molecular Therapeutics

Yongqiang Zhao
Shuangshuang Guo
Jia Liu
Yating Wang
Bo Wang
Chun Peng
Enqi Du

Frontiers in Immunology

doi 10.3389/fimmu.2025.1519866

116 views

Original Research

Accepted on 15 Jan 2025

Next-Generation Sequencing and Immuno-Informatics for Designing a Multi-Epitope Vaccine Against HSV-1-Induced Uveitis

in Vaccines and Molecular Therapeutics

He Cao
Zhi Cao
Yue Han
Jing Shan

Frontiers in Immunology

doi 10.3389/fimmu.2025.1461725

Original Research

Published on 14 Jan 2025

Impact of SARS-CoV-2 vaccination and of seasonal variations on the innate immune inflammatory response

in Vaccines and Molecular Therapeutics

Hend Jarras
Isalie Blais
Benjamin Goyer
Wilfried W. Bazié
Henintsoa Rabezanahary
Mathieu Thériault
Kim Santerre
Marc-André Langlois
Jean-François Masson
Joelle N. Pelletier

Frontiers in Immunology

doi 10.3389/fimmu.2024.1513717

152 views

Original Research

Published on 14 Jan 2025

Comparison of immune responses to SARS-CoV-2 spike following Omicron infection or Omicron BA.4/5 vaccination in kidney transplant recipients

in Vaccines and Molecular Therapeutics

Inga Tometten
Tobias Brandt
Maike Schlotz
Ricarda Stumpf
Sinje Landmann
Marta Kantauskaite
Joshua Lamberti
Jonas Hillebrandt
Lisa Müller
Margarethe Kittel

Frontiers in Immunology

doi 10.3389/fimmu.2024.1476294

376 views

Review

Published on 13 Jan 2025

DNA vaccines as promising immuno-therapeutics against cancer: a new insight

in Vaccines and Molecular Therapeutics

Alireza Shariati
Arya Khezrpour
Fatemeh Shariati
Hamed Afkhami
Aref Yarahmadi
Sajad Alavimanesh
Sina Kamrani
Mohammad Hossein Modarressi
Pouria Khani

Frontiers in Immunology

doi 10.3389/fimmu.2024.1498431

320 views

Original Research

Accepted on 10 Jan 2025

In silico design of a multi-epitope vaccine against Mycobacterium avium subspecies paratuberculosis

in Vaccines and Molecular Therapeutics

Weiqi Guo
Xinyu Wang
Jiangang Hu
Beibei Zhang
Luru Zhao
Guangdong Zhang
Jingjing Qi
Zuzhang Wei
Yanqing Bao
Mingxing Tian

Frontiers in Immunology

doi 10.3389/fimmu.2025.1505313

Original Research

Accepted on 09 Jan 2025

Discovery and in vitro characterization of a human anti-CD36 scFv

in Vaccines and Molecular Therapeutics

Cecilia Mata-Cruz
Sandra-Lucía Guerrero-Rodríguez
Keyla Gómez-Castellano
Gregorio Carballo-Uicab
Juan C Almagro
Sonia Mayra Pérez-Tapia
Marco A. Velasco-Velazquez

Frontiers in Immunology

doi 10.3389/fimmu.2025.1531171

Original Research

Published on 08 Jan 2025

Comprehensive analyses of immune activity in COVID-19-vaccinated idiopathic pulmonary fibrosis patients

in Vaccines and Molecular Therapeutics

Agata Maciejewska
Piotr Czernia
Magdalena Piotrowska-Mieczkowska
Beata Wajda
Bartosz Słomiński
Jan Romantowski
Adam Sudoł
Małgorzata Dąbrowska
Lucyna Górska
Tomasz Smiatacz

Frontiers in Immunology

doi 10.3389/fimmu.2024.1436491

460 views

Review

Published on 08 Jan 2025

Golgi protein 73: the driver of inflammation in the immune and tumor microenvironment

in Vaccines and Molecular Therapeutics

Pingping Feng
Xinyang Hu
Sining Zhou
Xianyong Liu
Linghui Zeng
Yiming Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1508034

162 views

Original Research

Published on 08 Jan 2025

Pomacea canaliculata hemocyanin as a novel natural immunostimulant in mammals

in Vaccines and Molecular Therapeutics

Ignacio Rafael Chiumiento
María Alejandra Tricerri
María Fernanda Cortéz
Santiago Ituarte
Julia Tau
Karina Valeria Mariño
Paola Lorena Smaldini
Horacio Heras
Marcos Sebastián Dreon

Frontiers in Immunology

doi 10.3389/fimmu.2024.1490260

267 views

Original Research

Accepted on 07 Jan 2025

Structural Engineering of Stabilized, Expanded Epitope Nanoparticle Vaccines for HPV

in Vaccines and Molecular Therapeutics

Michaela Helble
Xizhou Zhu
Pratik S. Bhojnagarwala
Kevin Liaw
Yangcheng Gao
Amber Kim
Kelly Bayruns
Madison E. McCanna
Joyce Park
Kylie M. Konrath

Frontiers in Immunology

doi 10.3389/fimmu.2025.1535261

128 views

Navigation group

Articles

Lymphoma patients treated with anti-CD20 and chemotherapy display disconnected T and B cell responses to COVID-19 vaccine

Brucella suis ΔmapB outer membrane vesicles as an acellular vaccine against systemic and mucosal B. suis infection

Serological cross-reactivity between Crimean-Congo haemorrhagic fever virus and Nairobi sheep disease virus glycoprotein C

Aspartate aminotransferase to platelet ratio correlates with poor prognosis and metabolic alterations in Dabie bandavirus infection

Editorial: Immune studies of SARS-CoV2 and vaccines using preclinical modeling

Adjuvant-free, self-assembling ferritin nanoparticle vaccine coupled with influenza virus hemagglutinin protein carrying M1 and PADRE epitopes elicits cross-protective immune responses

Next-Generation Sequencing and Immuno-Informatics for Designing a Multi-Epitope Vaccine Against HSV-1-Induced Uveitis

Impact of SARS-CoV-2 vaccination and of seasonal variations on the innate immune inflammatory response

Comparison of immune responses to SARS-CoV-2 spike following Omicron infection or Omicron BA.4/5 vaccination in kidney transplant recipients

DNA vaccines as promising immuno-therapeutics against cancer: a new insight

In silico design of a multi-epitope vaccine against Mycobacterium avium subspecies paratuberculosis

Discovery and in vitro characterization of a human anti-CD36 scFv

Comprehensive analyses of immune activity in COVID-19-vaccinated idiopathic pulmonary fibrosis patients

Golgi protein 73: the driver of inflammation in the immune and tumor microenvironment

Pomacea canaliculata hemocyanin as a novel natural immunostimulant in mammals

Structural Engineering of Stabilized, Expanded Epitope Nanoparticle Vaccines for HPV